A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
Clinical trial NCT04204616 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04204616
- Sponsor
- Galderma R&D
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2026-10-26
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.